High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants Journal Article


Authors: Razavi, P.; Li, B. T.; Brown, D. N.; Jung, B.; Hubbell, E.; Shen, R.; Abida, W.; Juluru, K.; De Bruijn, I.; Hou, C.; Venn, O.; Lim, R.; Anand, A.; Maddala, T.; Gnerre, S.; Vijaya Satya, R.; Liu, Q.; Shen, L.; Eattock, N.; Yue, J.; Blocker, A. W.; Lee, M.; Sehnert, A.; Xu, H.; Hall, M. P.; Santiago-Zayas, A.; Novotny, W. F.; Isbell, J. M.; Rusch, V. W.; Plitas, G.; Heerdt, A. S.; Ladanyi, M.; Hyman, D. M.; Jones, D. R.; Morrow, M.; Riely, G. J.; Scher, H. I.; Rudin, C. M.; Robson, M. E.; Diaz, L. A. Jr; Solit, D. B.; Aravanis, A. M.; Reis-Filho, J. S.
Article Title: High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Abstract: Accurate identification of tumor-derived somatic variants in plasma circulating cell-free DNA (cfDNA) requires understanding of the various biological compartments contributing to the cfDNA pool. We sought to define the technical feasibility of a high-intensity sequencing assay of cfDNA and matched white blood cell DNA covering a large genomic region (508 genes; 2 megabases; >60,000× raw depth) in a prospective study of 124 patients with metastatic cancer, with contemporaneous matched tumor tissue biopsies, and 47 controls without cancer. The assay displayed high sensitivity and specificity, allowing for de novo detection of tumor-derived mutations and inference of tumor mutational burden, microsatellite instability, mutational signatures and sources of somatic mutations identified in cfDNA. The vast majority of cfDNA mutations (81.6% in controls and 53.2% in patients with cancer) had features consistent with clonal hematopoiesis. This cfDNA sequencing approach revealed that clonal hematopoiesis constitutes a pervasive biological phenomenon, emphasizing the importance of matched cfDNA–white blood cell sequencing for accurate variant interpretation. © 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.
Journal Title: Nature Medicine
Volume: 25
Issue: 12
ISSN: 1078-8956
Publisher: Nature Publishing Group  
Date Published: 2019-12-01
Start Page: 1928
End Page: 1937
Language: English
DOI: 10.1038/s41591-019-0652-7
PUBMED: 31768066
PROVIDER: scopus
PMCID: PMC7061455
DOI/URL:
Notes: Article -- Export Date: 2 January 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Morrow
    766 Morrow
  2. Valerie W Rusch
    861 Rusch
  3. Mark E Robson
    676 Robson
  4. David Solit
    773 Solit
  5. Ronglai Shen
    203 Shen
  6. Alexandra S Heerdt
    110 Heerdt
  7. Marc Ladanyi
    1321 Ladanyi
  8. George Plitas
    105 Plitas
  9. Gregory J Riely
    598 Riely
  10. David Hyman
    354 Hyman
  11. Howard Scher
    1125 Scher
  12. Wassim Abida
    151 Abida
  13. Aseem Anand
    60 Anand
  14. Raymond Sear Lim
    57 Lim
  15. Charles Rudin
    483 Rudin
  16. Pedram Razavi
    168 Razavi
  17. David Randolph Jones
    413 Jones
  18. Krishna   Juluru
    35 Juluru
  19. Bob Tingkan Li
    275 Li
  20. James Michael Isbell
    126 Isbell
  21. Luis Alberto Diaz
    146 Diaz
  22. David Norman Brown
    88 Brown